The 5-HT1A receptor is the most widely distributed subtype of 5-HT receptor in the brain, especially in the hippocampus and prefrontal cortex, and is an important target for the clinical treatment of depression and anxiety disorders (Yohn et al., 2017). The gene discussed is HTR1A; the disease is depressive disorder.